• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube
CDE Almería – Centro de Documentación Europea – Universidad de Almería

CDE Almería - Centro de Documentación Europea - Universidad de Almería

Centro de Documentación Europea de la Universidad de Almería

  • HOME
  • WHAT´S ON
    • EU BULLETINS
    • EU NEWS
    • Activities
    • EU Calls and Awards
    • Radio Program «Europe with You»
  • DOCUMENTATION
    • Bibliographic Collection
      • Almería EDC Digital Collection
      • UNIVERSITY OF ALMERIA LIBRARY
    • Documentation by topic
    • EU Media Collection
      • Web Space
      • MEDIATHEQUE REPOSITORY
  • Europe on the net
    • Institutions
    • EU Representation in Spain
    • European information network of Andalusia
    • EU official journal
  • ABOUT US
    • Presentation
    • People
    • Contact
  • Spanish
  • English

High monkeypox vaccine acceptance among male users of smartphone-based online gay-dating apps in Europe

Inicio » Noticias UE » Sanidad » Diseases » High monkeypox vaccine acceptance among male users of smartphone-based online gay-dating apps in Europe

27 de October de 2022

Male adult users of smartphone-based online gay dating apps in the European region have high acceptance of monkeypox (MPX) vaccination. At the same time, there are specific groups with a high degree of vaccine hesitancy to whom campaigns should be tailored. Here, public health providers together with community-based organisations play an important role.

Plano detalle de una mano que sostiene un teléfono móvil con la aplicación Tinder

This is according to a Eurosurveillance report published on 20 October 2022, which used data from an online survey conducted on smartphone-based online gay dating apps in 52 countries in the European region. From 30 July to 12 August, the survey asked adults aged 18 and older about their acceptance of vaccinations. Some 33,000 users of the apps Grindr and Hornet participated in the survey. Users of the two apps were men who have sex with men (MSM).

The study provides guidance on how to implement an equitable MPX vaccination strategy. Results can be used to design vaccination strategies and health promotion efforts tailored to groups who may have higher vaccine hesitancy.

In general, there is a high level of vaccination acceptance among participants. Eighty-two percent of respondents said they would accept vaccination with MPX vaccines, nine percent were hesitant, and eight percent would decline vaccination. Factors cited for a high acceptance of MPX vaccination were:

  • a high degree of self-perception of being at risk to get infected of MPX,
  • conviction that MPX is a serious disease and
  • concerns about being treated differently because of MPX.

Evolution of monkeypox in Europe

 

 

These are key associated factors in determining the decision to be vaccinated, as has been described in other studies.

Also, being linked to routine healthcare was a positive predictor of willingness to be vaccinated. Acceptance of vaccination was also higher in certain cases among older respondents.

On the other hand, the results suggest geographic differences in MPX vaccination acceptance, with lower rates reported by people living in the south-eastern, central and eastern European subregions.

Vaccination campaigns and related services should therefore be tailored to the needs of those groups with higher vaccine hesitancy, such as young MSM, people living with HIV who are not receiving antiretroviral therapy, or those who perceive a lower risk of infection and who have fewer links to community-based organisations and the healthcare system.

 MPX vaccination strategies should be part of a combined prevention approach for strengthening prevention services and increasing equitable MPX vaccination access, engaging community, healthcare providers, civil society and public health professionals.

Source: European Centre for Disease Prevention and Control

Publicaciones relacionadas:

Spain to receive vaccines and antivirals against monkeypox EMA advises on intradermal use of Imvanex / Jynneos against monkeypox European Commission unveils EU vaccines strategy European Commission authorises first safe and effective vaccine against COVID-19 European Commission authorises second safe and effective vaccine against COVID-19

“This is a space for debate. All comments, for or against publication, that are respectful and do not contain expressions that are discriminatory, defamatory or contrary to current legislation will be published”.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Publicaciones relacionadas

Spain to receive vaccines and antivirals against monkeypox EMA advises on intradermal use of Imvanex / Jynneos against monkeypox European Commission unveils EU vaccines strategy European Commission authorises first safe and effective vaccine against COVID-19 European Commission authorises second safe and effective vaccine against COVID-19

Footer

Logotipo en negativo del Centro de Documentación Europea de Almería
  • CDE Almería
  • Edificio Parque Científico-Tecnológico (Pita)
  • Planta: 1ª, Despacho: 2904120.
  • Ctra. Sacramento s/n. Almería (Spain)
  • Teléfono: (+34) 950 015266

HOME
NEWS
DOCUMENTATION
EUROPE ON THE NET
ABOUT US

  • LEGAL NOTICE
  • PRIVACY POLICY
  • COOKIE POLICY
  • ACCESSIBILITY
  • SITEMAP

Copyright © 2023 CDE Almería · Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

<p>El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. ajustes</p>

Politica de privacidad

El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. <a href="/politica-de-cookies" rel="noopener" target="_blank">Más información</a>

Cookies estrictamente necesarias

Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.

Básicamente la web no funcionara bien si no las activas.

Estas cookies son:

  • Comprobación de inicio de sesión.
  • Cookies de seguridad.
  • Aceptación/rechazo previo de cookies.

Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.

Cookies de terceros

Esta web utiliza Google Analytics, Google Tag Manager y Yandex Metrika para recopilar información anónima tal como el número de visitantes del sitio, o las páginas más populares.

Dejar estas cookies activas nos permite mejorar nuestra web.

¡Por favor, activa primero las cookies estrictamente necesarias para que podamos guardar tus preferencias!

Política de cookies

Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. Más información